PRESS RELEASE published on 01/19/2024 at 23:05, 2 years 2 months ago ROSEN, A LEADING NATIONAL FIRM, Encourages British American Tobacco p.l.c. Investors to Inquire About Securities Class Action Investigation - BTI The Rosen Law Firm, a global investor rights law firm, is investigating potential securities claims on behalf of British American Tobacco p.l.c. (NYSE: BTI) shareholders for possible misleading business information. Shareholders who have purchased British American Tobacco securities may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. To join the prospective class action seeking recovery of investor losses, individuals can visit their website or contact their toll-free number or email for more information. The Rosen Law Firm has a successful track record in securities class actions and shareholder derivative litigation, including achieving the largest ever securities class action settlement against a Chinese Company and recovering hundreds of millions of dollars for investors. Rosen Law Firm Securities Class Action Investor Rights British American Tobacco Shareholder Compensation
PRESS RELEASE published on 01/19/2024 at 23:04, 2 years 2 months ago ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages ON Semiconductor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - ON The Rosen Law Firm, a leading global investor rights law firm, encourages ON Semiconductor Corporation investors to secure counsel before the important deadline in the securities class action. If you purchased onsemi common stock during the Class Period, you may be entitled to compensation. The Rosen Law Firm has a track record of success in leadership roles and represents investors worldwide. Act now to protect your rights and seek qualified counsel. Rosen Law Firm Securities Class Action Investor Rights ON Semiconductor Corporation Compensation
PRESS RELEASE published on 01/19/2024 at 22:02, 2 years 2 months ago ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Brooge Energy Limited Investors to Inquire About Securities Class Action Investigation - BROG The Rosen Law Firm, a global investor rights law firm, is investigating potential securities claims on behalf of shareholders of Brooge Energy Limited. The firm believes that Brooge may have issued misleading business information to the investing public, resulting in potential financial losses for investors. Interested investors are encouraged to contact the firm to inquire about joining the prospective class action and seeking recovery of investor losses without payment of any out-of-pocket fees or costs. Through its extensive experience and successful track record, The Rosen Law Firm has recovered substantial amounts for investors in securities class actions and shareholder derivative litigation, making them a reliable choice for investors seeking legal representation in such matters. Rosen Law Firm Investor Rights Securities Claims Brooge Energy Limited Class Action Investigation
PRESS RELEASE published on 01/19/2024 at 22:02, 2 years 2 months ago ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages LivePerson, Inc. Investors to Secure Counsel Before Important January 30 Deadline in Securities Class Action - LPSN Rosen Law Firm, a global investor rights law firm, encourages LivePerson, Inc. investors to secure counsel before the important January 30 deadline in the securities class action. The lawsuit alleges misleading statements and withholding of material information by LivePerson, leading to financial damages for investors. Investors may be entitled to compensation and are urged to seek qualified counsel to protect their rights. Rosen Law Firm Securities Class Action Investor Rights LivePerson Inc. Financial Damages
PRESS RELEASE published on 01/19/2024 at 21:04, 2 years 2 months ago ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BNTX The Rosen Law Firm, a global investor rights law firm, has announced the filing of a class action lawsuit on behalf of BioNTech SE investors. The lawsuit alleges that BioNTech made materially false and misleading statements regarding its business and operations, overstating demand for its COVID-19 vaccine and accumulating excess inventory. Investors who purchased BioNTech securities during the specified period may be entitled to compensation and are encouraged to seek qualified counsel before the March 12, 2024 deadline. Rosen Law Firm BioNTech SE Securities Class Action Investor Rights COVID-19 Vaccine
Published on 04/09/2026 at 19:15, 3 hours 9 minutes ago Murchison Minerals Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Published on 04/09/2026 at 16:00, 6 hours 24 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 7 hours 44 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 8 hours 24 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 8 hours 54 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 22:00, 24 minutes ago Invitation - First Quarter 2026 Trading Update Conference Call
Published on 04/09/2026 at 21:01, 1 hour 23 minutes ago GEVELOT S.A.: PRESS RELEASE CLOSING OF 2025 ACCOUNTS
Published on 04/09/2026 at 20:03, 2 hours 21 minutes ago Annual General Meeting approves all proposals
Published on 04/09/2026 at 18:15, 4 hours 9 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 18:35, 3 hours 49 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 15:57, 6 hours 27 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 15 hours 24 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 1 day 4 hours ago Publication of the 2025 Universal Registration Document